March 2026 in “Pediatrics in Review” This case report describes a 17-year-old boy with obesity who was diagnosed with severe hypothyroidism, leading to myopathy, rhabdomyolysis, acute kidney injury, and bradycardia. Following treatment with IV levothyroxine and liothyronine, his symptoms improved, and he achieved significant weight loss over five months.
November 1999 in “Reactions Weekly” June 2026 in “EP Europace” This study found that minoxidil and finasteride, commonly used for androgenetic alopecia, were associated with different arrhythmia profiles in adverse event reports: minoxidil predominantly with supraventricular arrhythmias and finasteride primarily with ventricular arrhythmias in men.
April 2023 in “Research Square (Research Square)” This study reported that 57% of healthcare workers experienced persistent post-COVID-19 complications, with common symptoms including hair loss, easy fatigability, mood swings, and anxiety.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.